华北制药(600812.SH)：腺苷钴胺胶囊获得药品注册证书

Core Viewpoint - North China Pharmaceutical has received approval from the National Medical Products Administration for the registration of Adenosylcobalamin capsules (0.5mg), which are designed to inhibit abnormal fat synthesis in nerve myelin and promote the repair of damaged nerves [1] Group 1: Product Details - Adenosylcobalamin is effective in preventing and treating vitamin B12 deficiency, particularly in cases where dietary intake is insufficient due to conditions such as consuming diseases, hyperthyroidism, pregnancy, and lactation [1] - The product aids in normalizing glutathione levels, protecting nerve cells, and improving anemia by participating in heme synthesis [1] Group 2: Mechanism of Action - The drug blocks the occurrence and development of demyelination in nerve fibers and promotes protein and lipid synthesis [1] - It lowers abnormal TNFα levels, inhibits the occurrence of SACD, and participates in the tricarboxylic acid cycle to maintain normal cellular functions [1]